Cochrane · systematic review · CD010327
Combination inhaled corticosteroids and long‐acting beta₂‐agonists for children and adults with bronchiectasis
Goyal, V, Chang, AB · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
AirwaysAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: 18 to 80 years of age with bronchiectasis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
SGRQ Scores range from 0 to 100, with higher scores indicating more limitations | no estimate extracted | 1 study · 40 participants | Low Downgraded: imprecision |
TDI Total scores range from ‐ 9 to +9. The lower the score, the greater the deterioration in severity of dyspnoea, MCID ≥ 1 | MD 1.29 [0.4, 2.18] | 1 study · 40 participants | Low Downgraded: imprecision |
Cough‐free days Percentage of days free of cough | MD 12.3 [2.38, 22.22] | 1 study · 40 participants | Low Downgraded: imprecision |
Hospitalisations, number of participants with 1 or more exacerbations | OR 0.26 [0.02, 2.79] | 1 study · 38 participants | Low Downgraded: imprecision |